Patent details

EP2124999 Title: ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING ANEMIA

Basic Information

Publication number:
EP2124999
PCT Application Number:
PCT/US/2007/025868
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP078630688
PCT Publication Number:
WO/2008/076437
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING ANEMIA
French Title of Invention:
ANTAGONISTES DE L'ACTIVINE-ACTRII ET SES UTILISATIONS POUR LE TRAITEMENT DE L'ANÉMIE
German Title of Invention:
ACTIVIN-ACTRII-ANTAGONISTEN UND IHRE VERWENDUNGEN ZUR BEHANDLUNG VON ANÄMIE
SPC Number:

Dates

Filing date:
18/12/2007
Grant date:
03/10/2012
EP Publication Date:
03/10/2012
PCT Publication Date:
26/06/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/12/2009
EP B1 Publication Date:
03/10/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/12/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/07/2013
 
 

Name:
Acceleron Pharma Inc.
Address:
128 Sidney Street, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
17/10/2012
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
SHERMAN Matthew L.
Address:
United States (US)

Priority

Priority Number:
875682 P
Priority Date:
18/12/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/17;

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
19
Annual Fee Amount:
281 Euro
Expected Payer:
Last Annual Fee Payment Date:
12/11/2024
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages